{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication via OTC swaps, Inverse exposure, Counterparty risk",
    "classification": "complex",
    "supporting_data": "The Amundi MSCI USA Daily (-1x) Inverse UCITS ETF Acc is a UCITS ETF that aims to provide a 2x inverse daily exposure to the S&P 500 index via indirect replication using an over-the-counter (OTC) swap contract, a financial derivative instrument. This synthetic replication method involves counterparty risk and collateral risk, which are complex features under MiFID II. The ETF uses leverage (2x inverse exposure), which is significant and beyond typical UCITS borrowing limits, contributing to complexity. The ETF's structure and risks, including the use of derivatives integral to its investment objective, inverse and leveraged exposure, and counterparty risk, are difficult for a retail investor with basic knowledge to understand. According to MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, such features classify the ETF as complex. The ETF is UCITS compliant but due to its synthetic replication, embedded derivatives (swaps), leverage, and inverse strategy, it fails the criteria for non-complex instruments. Therefore, it requires an appropriateness assessment before sale to retail investors. This aligns with ESMA guidance that synthetic ETFs and leveraged/inverse ETFs are complex products requiring investor protection measures. The ETF does not use physical replication, and its derivative use is central to its strategy, not limited to efficient portfolio management. Securities lending is not mentioned as a factor here. The ETF's risk profile includes counterparty risk and leverage risk, which are complexity drivers under MiFID II. Hence, the classification is complex."
}